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ARTICLE
NK cells are activated and primed for skin-homing
during acute dengue virus infection in humans
Christine L. Zimmer1, Martin Cornillet1, Carles Solà-Riera1, Ka-Wai Cheung2, Martin A. Ivarsson1, Mei Qiu Lim2,
Nicole Marquardt 1, Yee-Sin Leo3,4,5,6, David Chien Lye 3,5,6, Jonas Klingström 1, Paul A. MacAry7,
Hans-Gustaf Ljunggren1, Laura Rivino2,8,9 & Niklas K. Björkström 1,9
Despite animal models showing that natural killer (NK) cells are important players in the
early defense against many viral infections, the NK cell response is poorly understood in
humans. Here we analyze the phenotype, temporal dynamics, regulation and trafﬁcking of NK
cells in a patient cohort with acute dengue virus infection. NK cells are robustly activated and
proliferate during the ﬁrst week after symptom debut. Increased IL-18 levels in plasma and in
induced skin blisters of DENV-infected patients, as well as concomitant signaling down-
stream of the IL-18R, suggests an IL-18-dependent mechanism in driving the proliferative NK
cell response. Responding NK cells have a less mature phenotype and a distinct chemokine-
receptor imprint indicative of skin-homing. A corresponding NK cell subset can be localized
to skin early during acute infection. These data provide evidence of an IL-18-driven NK cell
proliferation and priming for skin-homing during an acute viral infection in humans.
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Natural killer (NK) cells are innate lymphocytes importantin the early immune response against many viral infec-tions1–3. From experimental model systems, it is known
that NK cells participate in the control of acute infections by
many different viruses3,4. In humans, their importance is
underscored in rare NK cell deﬁciencies, resulting in a high
susceptibility to many viral and other infections5. Furthermore,
recent work has shown that human NK cells are activated and/or
expanded during numerous viral infections6–12. However, many
details are missing with respect to how an early NK cell response
to an acute viral infection is driven in humans.
Human NK cells are divided into two phenotypically and
functionally distinct subsets based on their expression of CD56:
CD56bright and CD56dim NK cells. CD56bright NK cells are pro-
minent in peripheral organs where they primarily respond to
cytokines and exhibit immunoregulatory functions by virtue of a
profound cytokine and chemokine-producing capacity. CD56dim
NK cells are prone to target cell interaction and, as a con-
sequence, have high cytotoxic as well as cytokine-producing
capacities, and constitute the dominant NK cell population in
peripheral blood1,13. NK cell activation is regulated by signals
from activating and inhibitory receptors, as well as cytokine and
chemokine receptors3,13,14. A process referred to as NK cell
education further modulates their responsiveness, rendering NK
cells more functionally potent to missing self. Education occurs
predominantly via interactions between inhibitory KIRs and
NKG2A, and their respective cognate histocompatibility leuko-
cyte antigen (HLA) class I ligands15,16. In addition to education,
NK cells undergo a regulated differentiation process during which
both phenotypic and functional changes occur17.
Early in infection, NK cells are activated by cytokines such as
type I interferons, interleukin-12 (IL-12), IL-15, and IL-181–3.
This activation may initiate changes in cell signaling pathways,
which ultimately impact NK cell effector responses18,19. These
include directed killing of infected cells via death receptors or
directed release of cytotoxic granules containing perforin and
granzymes, as well as the production and release of anti-viral
cytokines13,20. However, pathogen clearance also requires rapid
recruitment of immune cells to target organs. Over the past
decade, progress has been made in the development of experi-
mental model systems elucidating homing mechanisms for NK
cells during infections in mice21,22. These studies have revealed
the importance of distinct chemokine–chemokine receptor pairs
in NK cell recruitment to liver, lung, gut, and central nervous
system23–29. However, little is known about NK cell trafﬁcking to
peripheral organs in humans during acute viral infections.
Dengue virus (DENV) infection is a mosquito-borne viral
disease annually affecting up to 400 million individuals world-
wide30. Here, we perform an in-depth evaluation of the early NK
cell response following DENV infection in a cohort of patients
suffering from dengue fever (DF). Patients with acute DENV
infection are recruited and followed from the onset of clinical
symptoms until resolution of disease and beyond. Using a high-
dimensional unsupervised analysis approach, we comprehen-
sively analyze the NK cell response. The results show that both
CD56bright and a subpopulation of CD56dim NK cells respond
vigorously to the acute infection. This occurs irrespectively of
their educational status and no evidence for speciﬁc adaptive-like
NK cell responses is noted. Increased levels of plasma and skin
IL-18 are observed during acute infection and are shown to
induce signaling downstream of the IL-18R in NK cells, sug-
gesting a pivotal role for IL-18 in the induction of the NK cell
responses. Finally, the CD56bright NK cell population expresses
chemokine receptors associated with homing to organs com-
monly affected during the natural course of clinical DENV
infection including the skin. In conclusion, our results provide
novel insights into the dynamics and speciﬁcs of the early NK cell
response during an acute viral infection in humans.
Results
NK cells are robustly activated during acute DENV infection.
To investigate the NK cell-mediated immune response during
acute DENV infection, 32 patients were followed longitudinally
from an early stage of infection, after symptom debut to the
post-febrile phase and into convalescence. All, except for one,
of the included patients presented with DF, a normal pre-
sentation of acute DENV infection. Detailed clinical char-
acteristics of the cohort are described in Supplementary Table
1. First, we analyzed the NK cell response in the patients
throughout the course of infection (Fig. 1a–d, Supplementary
Fig. 1a–c). A high percentage of both CD56bright and CD56dim
NK cells were stained positive for the proliferation marker Ki67
at the acute phase of infection (Fig. 1a, b). The frequency of
Ki67-expressing NK cells subsequently declined throughout the
post-febrile and convalescent phases. A similar pattern of
activation marker expression was seen for CD69 as well as for
CD38, the latter depicted as median ﬂuorescence intensity
(MFI), albeit with lower percentages of CD69 expression on
CD56bright NK cells during the acute phase of infection (Fig. 1c,
d). Of note, the expression of Ki67 and CD69 was largely
mutually exclusive. CD56dim NK cells are known to undergo a
regulated differentiation process17. No remarkable changes in
frequencies of NK cells in peripheral blood were observed
throughout the infection in DENV-infected patients (Supple-
mentary Fig. 1b, c). To further characterize the responding
CD56dim NK cells during the acute phase of infection, Ki67
expression was assessed in relation to distinct CD56dim NK cell
differentiation stages17. Notably, responding cells were pre-
dominantly observed among less mature CD57− cells, while
more mature CD57+ cells showed a markedly lower response in
terms of activation (Fig. 1e, f, Supplementary Fig. 1d, e). Taken
together, immature NK cells were robustly activated during
acute DENV infection. This prompted us to perform a more in-
depth analysis of the responding cells.
Responding NK cells exhibit an immature phenotype. The
ability to simultaneously compare the detailed phenotype of
responding and non-responding NK cells in multiple patients can
provide a better understanding of the exact nature of the NK cell
response observed. For this purpose, Flow Cytometry Standard
(FCS) ﬁles containing populations of responding (Ki67+) and
non-responding (Ki67−) CD56bright and CD56dim NK cells,
respectively, from patients with acute infection were assigned
electronic barcodes. The FCS ﬁles were concatenated and ana-
lyzed with stochastic neighbor embedding (SNE). SNE is a
dimensionality reduction algorithm that generates two-
dimensional representations of ﬂow cytometry data at the
single-cell level while preserving local and global geometry of the
data31,32. Eleven distinct NK cell receptors, simultaneously
stained for, were selected for clustering and two-dimensional
maps of responding and non-responding NK cells were con-
structed (Fig. 2a–d). By generation of residual plots, considerable
differences in multi-dimensional space between responding and
non-responding CD56bright and CD56dim NK cells were revealed
(Fig. 2a, c).
Based on the obtained SNE maps, expression intensities of the
11 parameters within the clusters of differentially abundant cells
were evaluated (Fig. 2b, d). This revealed responding CD56bright
NK cells to show only minor differences in phenotype compared
to non-responding CD56bright NK cells (Fig. 2b). On the other
hand, responding CD56dim NK cells displayed a clearly less
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differentiated phenotype compared to non-responding CD56dim
NK cells, as identiﬁed by lower expression of CD57, NKG2C, and
DNAM-1 and higher expression of NKp30 and NKp46 (Fig. 2d).
Results from the SNE analysis were largely corroborated by
results from conventional single-parameter ﬂow cytometry data
analysis (Supplementary Fig. 2a–c). Furthermore, while the
expression of the anti-apoptotic molecule Bcl-2 was observed to
be slightly down-regulated in responding CD56bright and
CD56dim NK cells (Fig. 2b, d–f), the downregulation was modest
in magnitude compared to the downregulation of Bcl-2 observed
in responding T cells from the same patients (Fig. 2e, f).
Additionally, responding CD56bright NK cells upregulated the
effector molecules granzyme B and perforin (Supplementary Fig.
2d, e).
In summary, high-dimensional SNE analysis revealed respond-
ing NK cells to exhibit a less mature phenotype (i.e.,
predominantly CD56bright and less differentiated CD56dim NK
cells) during acute DENV infection.
The NK cell response is uncoupled from education. Next, we
investigated whether the NK cell response during acute DENV
infection was coupled to KIR expression or KIR-mediated NK cell
education15,16. Murine experimental models have suggested that
uneducated NK cells dominate anti-viral responses33. However,
our analysis revealed that NK cells responded equally well inde-
pendently of the number of KIRs expressed (Supplementary Fig.
3a, b). Furthermore, their response occurred independently of
KIR-mediated education (Supplementary Table 2, Fig. 3a, b).
Since NKG2A can also educate NK cells34, and our analysis
revealed NKG2A expression (expressed on many immature cells)
to be associated with NK cell responsiveness (Fig. 1e), we strati-
ﬁed for education mediated by NKG2A expression. However, also
in this respect, NK cells responded independently of their edu-
cational status (Fig. 3c and Supplementary Fig. 3c). Moreover,
expansions of NKG2C-expressing NK cells have previously been
shown to occur in some human viral infections and are skewed
towards the expression of self-KIR6,9,35,36. We identiﬁed two
b c
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Fig. 1 Natural killer (NK) cells are robustly activated during the acute phase of dengue virus (DENV) infection. a Representative staining for CD69 and Ki67
expression on NK cells from one representative patient during the acute, post-febrile, and convalescent phase of DENV infection, and one healthy control.
Summary of data showing b Ki67, c CD69 (acute, n= 31; post -febrile, n= 29; convalescent, n= 29; healthy control, n= 26), and d CD38 (acute, n= 10;
post -febrile, n= 9; convalescent, n= 10; healthy control, n= 13) expression on CD56bright and CD56dim NK cells shown as median ﬂuorescence intensity
(MFI), respectively. e, f Summary of data on e Ki67 and f CD69 expression on CD56bright as well as CD56dim NK cell subsets, respectively. The CD56dim
NK cells are stratiﬁed by differential expression of NKG2A and CD57. NK cells from DENV-infected patients at the acute (n= 25) and convalescent (n=
23) phases of infection. Statistical differences were tested using one-way analysis of variance (ANOVA) and Kruskal–Wallis test followed by Tukey’s
multiple comparisons test or Dunn’s multiple comparisons test, respectively. Bars represent mean, *p < 0.05, **p < 0.01, ***p < 0.001. Source data are
provided as a Source Data ﬁle
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Fig. 2 High-dimensional analysis of natural killer (NK) cells responding (Ki67+ and Ki67−) during acute dengue virus (DENV) infection. a Barnes–Hut
stochastic neighbor embedding (Bh-SNE) maps on total CD56bright NK cells and separated for responding (Ki67+) and non-responding (Ki67−) cells.
Residual plot showing the difference between responding and non-responding maps. Analysis is based on data from three representative patients at the
acute phase of infection with 5000 events per subset and patient. b Relative expression intensities of the 11 indicated parameters that were used in the SNE
analysis. Phenotypes within red circles are more common in responding NK cells and vice versa for blue circles in non-responding NK cells. c, d Similar
analysis as in a, b but for CD56dim NK cells. e Representative ﬂow cytometry staining for Bcl-2 and Ki67 expression of T cells, CD56bright NK cells, and
CD56dim NK cells from one representative patient at the acute phase of infection. f Comparison of Bcl-2 expression using the median ﬂuorescence
intensity ratio (MFI, ratio of Ki67+ normalized to Ki67−) within T cells, CD56bright NK cells, and CD56dim NK cells (n= 9). Lowest and highest
observations are displayed with the median indicated as center line. Statistical differences in f were tested using one-way analysis of variance (ANOVA)
followed by Holm–Sidak’s multiple comparison test. *P < 0.05 and ***p < 0.001. Source data are provided as a Source Data ﬁle
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patients with adaptive-like NK cell expansions, characterized by
high expression of NKG2C and CD57 (Fig. 2d). However, these
adaptive-like NK cells were not preferentially responding during
acute infection in these individuals (Fig. 3d, e).
Several DENV serotypes exist and acute infection with one
DENV serotype typically confers long-term protective immunity
against that serotype but not against heterotypic DENV37. Thus,
secondary (and even tertiary) acute DENV infections can occur.
Since all four DENV serotypes are endemic in Singapore, this
presented an opportunity to compare NK cell responses in acute
primary vs. acute secondary DENV infection in patients who
were classiﬁed based on rapid tests performed at the clinic at the
time of patient recruitment. However, this analysis revealed the
NK cell response to be similar in magnitude (Fig. 3f, g).
Taken together, the acute NK cell response to DENV infection
is uncoupled from NK cell education with no evidence for an
adaptive-like NK cell response to a heterotypic DENV infection.
Acute DENV infection presents with increased IL-18 levels. We
next sought to identify mechanistic aspects of the robust NK cell
activation observed in acute DENV infection. We hypothesized
that the preferential activation of less mature NK cells might be
driven by soluble factors. To address this, we ﬁrst performed a
comprehensive analysis of cytokines and soluble factors in plasma
from infected patients. A vast number of factors, including pro-
inﬂammatory and anti-viral cytokines, as well as effector mole-
cules associated with cytotoxicity, were signiﬁcantly elevated in
the acute phase as compared to the convalescent phase and
healthy controls (Supplementary Fig. 4). The NK cell-activating
cytokines, interferon-α (IFNα), IL-12, and IL-15, were sig-
niﬁcantly elevated during the acute phase of infection (Supple-
mentary Fig. 4), but the detected levels were relatively low.
Compared to IFNα, IL-12, and IL-15, the plasma levels of IL-18
were robustly increased during the acute phase of DENV infec-
tion (Fig. 4a and Supplementary Fig. 4). This is strikingly similar
to observations in a mouse model of cytomegalovirus (CMV)
infection where IL-18 was critical in driving the anti-viral NK cell
response38. Additionally, high IL-18Rα expression was observed
on NK cells (Fig. 4b), especially on CD56bright and less mature
CD56dim NK cell subsets during the acute phase of the infection
(Fig. 4b, c). Notably, the expression levels were signiﬁcantly
higher than that on T cells (Fig. 4c).
We also investigated whether the skin microenvironment, one
of the organs with clinical manifestation in the patients, also
contained IL-18. To this end, skin blisters were induced on the
forearms of patients with DENV infection, causing the detach-
ment of epidermis from dermis and permitting minimally
invasive sampling of serous ﬂuid from the skin. Interestingly,
IL-18 was found at even higher levels in skin blister ﬂuid from
DENV patients collected during the acute phase of the infection
as compared to plasma (Fig. 4d). On the other hand, only low
levels of IL-2, IL-12, and IL-15 could be detected (Fig. 4d).
Interestingly, a recent in vitro study on murine NK cells showed a
speciﬁc role for IL-18 in driving NK cell proliferation via
upregulation of the nutrient transporter CD98 independently of
mammalian target of rapamycin, whereas no effect on CD98
upregulation was seen for other NK cell stimulatory cytokines39.
In line with this, we could demonstrate that NK cells from
patients with acute DENV infection expressed higher levels of
CD98 as compared to controls (Fig. 4e). Thus, we decided to
explore further a potential role of IL-18 in driving the activation
of less mature NK cells during acute DENV infection.
IL-18 signaling is linked to the NK cell response. In order to
analyze an association between IL-18 and the activation of NK
cells, we used phosphoﬂow to monitor signaling of key pro-
teins and transcription factors downstream of the IL-18R
known to be positive (AKTpT308/S473, ATF2pT69/71, NF-
kBpS529) or negative (FOXO3ApS294) regulators of the cell
cycle (Supplementary Fig. 5a)40–43. Using peripheral blood
mononuclear cells (PBMCs) from healthy controls, we iden-
tiﬁed key NK cell subsets of interest (Fig. 5a) and detected
phosphorylation of the targeted proteins upon IL-18 stimula-
tion in vitro (Fig. 5b, c). The responses observed were parti-
cularly marked within less mature CD56dim NK cell subsets
(Fig. 5c). An enhancement of signaling downstream of IL-18
was also observed when PBMCs were exposed to acute com-
pared to convalescent phase plasma from DENV-infected
patients in combination with IL-18 (Fig. 5d, Supplementary
Fig. 5c). Following this analysis, and as a critical test
of our hypothesis, we determined correlates of IL-18R sig-
naling directly on NK cells ex vivo from the DENV-infected
patients. Here, we detected an IL-18 signaling signature with
higher amount of phosphorylation linked to progression
(pATF2, pAKT, pNF-kB) and de-repression of the cell
cycle (pFOXO3A) during the acute phase of the infection (Fig.
5e, Supplementary Fig. 5d). This proﬁle was normalized
to levels of healthy controls during the post-febrile and
convalescent phase (with the exception of nuclear factor-κB
(NF-κB)).
Taken together, these results suggest that IL-18 contributes to
the activation of less mature NK cells during acute DENV
infection by coordinating activation and de-repression of the
cell cycle.
Assessment of NK cell function during acute DENV infection.
After determining the phenotype and signaling properties of
NK cells during acute DENV infection, we next examined
potential alterations in their functional capacity. To this end,
NK cells were assessed for natural cytotoxicity responses,
antibody-dependent cellular cytotoxicity, and responses fol-
lowing cytokine stimulation. Five NK cell functions (degra-
nulation assessed by CD107a expression and production of
IFNγ, tumor necrosis factor (TNF), macrophage inﬂammatory
protein-1β (MIP-1β), and granulocyte–macrophage colony-
stimulating factor (GM-CSF)) were simultaneously evaluated.
As expected, the proﬁle of the response changed depending on
the type of stimulation and on the type of NK cell subset
(CD56bright vs. CD56dim) examined (Fig. 6a). Intriguingly, NK
cells retained their functional response proﬁle during acute
DENV infection (Fig. 6b). Similarly, the total frequency of
responding cells as well as the multifunctional response proﬁle
was unaffected during acute infection (Fig. 6b, c). Since the NK
cell response to IL-12 and IL-18 stimulation was near satura-
tion, we also assessed the functional proﬁle upon stimulation
with lower concentrations of IL-12 and IL-18. Also in this
setting, the NK cell functional response was largely retained in
acute DENV infection, but with slightly lower levels of IFNγ
being produced from both CD56bright and CD56dim NK cells
(Supplementary Fig. 6a–c). Finally, we determined the capacity
of NK cells to respond upon in vitro infection of PBMCs with
DENV. Upon DENV infection, both CD56bright and CD56dim
NK cells upregulated CD69, whereas only CD56bright NK cells
showed evidence of TRAIL expression (Supplementary Fig.
7a). Furthermore, NK cells responded by producing IFNγ,
TNF, and MIP-1β (Fig. 6d).
Together, these results indicate that NK cells from DENV-
infected patients preserve their functional capacity throughout
the infection and that NK cells have the capacity to respond to
DENV infection of PBMCs in vitro.
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Speciﬁc chemokine receptor imprint on CD56bright NK cells.
Little is known regarding NK cell homing to peripheral tissues
during acute viral infections in humans. Patients with acute
DENV infection often show disease manifestations in the skin,
liver, and gut44. To investigate whether NK cells might be primed
for homing to peripheral tissues during acute DENV infection, we
determined the chemokine receptor proﬁle of Ki67+/CD69+ and
Ki67−/CD69− CD56bright and CD56dim NK cells, respectively,
during the acute phase of infection. T cells were included as a
positive control since upregulation of cutaneous lymphocyte-
associated antigen (CLA), CCR5, and CXCR3 on DENV-speciﬁc
T cells has recently been described in acute DENV infection45,
and was conﬁrmed in the present study (Supplementary Fig. 8a,
b). Strikingly, responding Ki67+ CD56bright NK cells expressed
higher levels of CLA, CCR5, CXCR6, and CCR9 as compared to
both non-responding NK cells during the acute phase of infection
as well as healthy controls. In contrast, CCR7 was down-
modulated in responding Ki67+ CD56bright NK cells (Fig. 7a, b).
A similar pattern, albeit with lower chemokine receptor expres-
sion, was observed for responding CD56dim NK cells. Responding
CD69+ CD56bright NK cells showed a varying pattern of che-
mokine receptor expression with high expression of CCR5 and
CXCR6, as well as an intermediate increase in α4β7 and CCR6
(Fig. 7b). The increased chemokine receptor expression was
diminished in follow-up samples where expression levels returned
to those observed in healthy controls (Fig. 7b). In summary, our
data revealed that responding NK cells exhibit a distinct che-
mokine receptor proﬁle during acute DENV infection.
CLA+CD69+ CD56bright NK cells are present in skin. The high
expression of CLA suggests that responding NK cells may home
to the skin during acute DENV infection. To investigate this, skin
blisters were induced on the forearms of acute DENV-infected
patients and healthy controls, as described above for skin blister-
ﬂuid sampling. Flow cytometry analysis of blister-ﬂuid cells
revealed that skin NK cells were enriched for NK cells of the
CD56bright subset (Fig. 8a, b). Moreover, in the patients, we found
a negative correlation between the total number of NK cells per
skin blister and number of days that had passed since symptom
debut (Fig. 8c). Skin NK cells from patients with acute DENV
infection expressed high levels of CLA and roughly half of the
cells concomitantly stained positive for CD69 (Fig. 8d, f). Of note,
CD69 not only identiﬁes activated lymphocytes but also cells with
a tissue-resident phenotype46,47. In contrast to this, fewer skin
NK cells from healthy controls co-expressed CLA and CD69 (Fig.
8d, f). Finally, the chemokine receptor expression pattern on skin
NK cells from patients with acute DENV infection mirrored the
proﬁle in peripheral blood with increased expression of CXCR3
and CCR5, but low expression of CCR7 and CCR10 (Fig. 8e, g).
Our results suggest that responding CLA+CXCR3+CCR5+
CD56bright NK cells have the capacity to home to the site of
infection (skin) during acute DENV infection.
Discussion
To explore the primary human NK cell response to acute
DENV infection, we followed a cohort of patients from early on
after onset of symptoms until disease resolution. Our results
showed that NK cells responded strongly during the acute
phase of infection. High-dimensional SNE analysis revealed
that responding NK cells displayed a predominantly less mature
phenotype (CD56bright and immature CD56dim cells) with
retained functional capacity. Elevated levels of IL-18 in patient
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plasma and skin blister ﬂuid, and correlates of signaling
downstream the IL-18Rα in the responding NK cells, indicated
an IL-18-mediated mechanism behind this speciﬁc response
proﬁle. Responding CD56bright NK cells furthermore presented
with a chemokine receptor imprint indicative of homing to skin
and liver. Concurrent with these observations, CD69+CLA
+CXCR3+CCR5+ NK cells were identiﬁed in the skin during
acute DENV infection.
NK cell differentiation is a continuous homeostatic process
associated with phenotypic and functional changes that can
adapt in response to viral infections17,48. Indeed, acute viral
infections, such as hantavirus, chikungunya virus, human
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immunodeﬁciency virus type 1, and Epstein–Barr virus (EBV)
infection, can lead to expansion of adaptive-like NK cell
populations exhibiting a mature differentiation
phenotype6,9,10,12,49. Such adaptations have often been attrib-
uted to underlying CMV infection where responding mature
cells are characterized by high levels of NKG2C, CD57, and
DNAM-1, and typically do not express NKG2A and natural
cytotoxicity receptors10,36,50. In our analysis, no expansions of
adaptive-like NK cells were observed in acute DENV infection.
Corroborating these ﬁndings, two patients identiﬁed with
Fig. 6 Assessment of natural killer (NK) cell function during acute dengue virus (DENV) infection. a Representative ﬂow cytometry staining shown as
concatenated plots for CD107a, interferon-γ (IFNγ), tumor necrosis factor (TNF), macrophage inﬂammatory protein-1β (MIP-1β), and
granulocyte–macrophage colony-stimulating factor (GM-CSF) for CD56bright and CD56dim NK cells after the indicated stimulations. Gates were set
according to unstimulated cells (no target). Numbers within gates indicate percent positive cells. Rit, Rituximab®. b Heat map summarizing the frequency of
CD56bright NK cells and CD56dim NK cells responding to the indicated stimulations (K562 cells, n= 4; 721.221 cells, n= 9; 721.221 cells+ Rituximab®, n=
9; IL-12+ IL-18, n= 4; IL-12+ IL-18+ K562 cells, n= 4) during the acute, post-febrile, and convalescent phase of DENV infection, and healthy controls. c
Pie charts showing the number of functions, as deﬁned by Boolean gating, simultaneously exhibited by CD56bright (left panels) and CD56dim (right panels)
NK cells either at the acute (upper panels) or convalescent phase (lower panels) of DENV infection in response to the indicated stimuli. The number of
functions (one to ﬁve) is shown in different shades of gray, and the outer arcs indicate which functions were detected within each pie. d Frequency of
CD56bright NK cells and CD56dim NK cells responding with IFNγ, TNF, and MIP-1β production upon in vitro infection of healthy donor peripheral blood
mononuclear cells (PBMCs) with live DENV (DENV), DENV pre-incubated with the chimeric 4G2 monoclonal antibody (mAb) (DENV+Ab), ultraviolet
(UV)-inactivated DENV (DENV UV), UV-inactivated DENV pre-incubated with the chimeric 4G2 mAb (DENV UV+Ab), and with 4G2 antibody only (Ab)
for 24 h. Medium control was subtracted. Statistical differences were tested using paired t test or Wilcoxon’s matched-pairs signed-rank test. *P < 0.05 and
**p < 0.01; n.s. not signiﬁcant. Source data are provided as a Source Data ﬁle
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adaptive-like NK cell expansions demonstrated no preferential
responsiveness attributed to these expansions during acute
infection. Moreover, we did not ﬁnd the NK cell response to be
superior during acute secondary DENV infection, which would
further argue against an adaptive-like NK cell component in the
response to acute DENV infection. Rather, a high-dimensional
11-parameter SNE analysis revealed responding NK cells to
exhibit a less differentiated phenotype with high expression of
NKG2A and NCRs, and low expression of CD57, NKG2C, and
DNAM-1. As such, our results are more in line with the NK cell
response following live attenuated yellow fever virus (YFV)
vaccination or that seen in acute EBV infection causing infec-
tious mononucleosis7,51.
NK cells expressing inhibitory KIRs or NKG2A are known to
undergo an education process leading to increased
functionality15,16. However, it remains unclear if NK cell educa-
tion is a determining factor for NK cell responses in infectious or
inﬂammatory conditions in humans. In mice infected with Lis-
teria monocytogenes, educated and uneducated NK cells produced
equivalent amounts of IFNγ52, and primarily uneducated NK
cells controlled murine CMV infection33. Human NK cells are
predominantly educated via NKG2A and inhibitory KIRs16. Our
data show that educated and uneducated NK cells responded to a
similar extent during acute DENV infection. This is in contrast to
the adaptive-like NK cell expansions appearing in certain infec-
tions. The latter are often characterized by the absence of NKG2A
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and the expression of self-speciﬁc inhibitory (educating) KIRs6,50.
Instead, our results corroborate recent reports studying NK cell
responses following YFV vaccination and tick-borne encephalitis
virus (TBEV) infection7,8. In this regard, it is known that less
differentiated NK cells are more responsive to cytokine stimula-
tion as compared to more differentiated cells and that NK cell
education status does not impact cytokine responsiveness17. Since
the observed response occurred independently of education, it is
plausible that it is primarily driven by soluble factors. Indeed, we
could detect signiﬁcantly elevated levels of several cytokines
known to promote NK cell activation during the acute phase of
infection, including IL-18.
In respect to the elevated levels of IL-18 in plasma and skin, we
hypothesized that IL-18 might drive NK cell activation and
proliferation of less mature NK cell subsets. This hypothesis was
further underscored by the observed upregulated levels of the
nutrient transporter CD98 on NK cells during acute DENV
infection. IL-18 was recently shown to drive murine NK cell
proliferation via upregulation of CD9839. Therefore, we explored
evidence of IL-18 signaling by studying NF-κB, AKT, ATF2, and
FOXO3A phosphorylation, signaling molecules that have all been
described to be involved in cell cycle regulation and survival40–43.
Indeed, less mature NK cells responded via these pathways upon
IL-18 stimulation in vitro. Furthermore, we found that NK cells
analyzed ex vivo during the acute phase of infection had sig-
niﬁcantly elevated levels of phosphorylated ATF2 and FOXO3A.
ATF2 induces proteins promoting the cell cycle, such as cyclins
and the anti-apoptotic molecule Bcl-241. FOXO3A, located
downstream of AKT signaling, actively represses the cell cycle in
the nucleus by inhibition of several proteins (cyclins, cyclin-
dependent kinases) and is inactivated upon phosphorylation via
cytoplasmic translocation followed by degradation43. NF-κB, also
found to be elevated in the patients, is known to trigger the
translation of adhesion and anti-apoptotic proteins, inﬂammatory
cytokines, certain chemokine receptors (CCR5), and activation
markers (CD69)42. These were all found to be elevated on NK
cells during the acute phase of infection, thereby promoting
survival and migration. Notably, the NK cell-activating cytokines,
IFNα, IL-12, and IL-15, were also elevated during the acute phase
of the infection. Even though we could only detect low levels of
these cytokines, they may also take part in promoting NK cell
proliferation. For example, cytokine-activated NK cells upregulate
the IL-2Rα subunit and respond to low concentrations of IL-253.
Moreover, signaling cascades are complex and also other stimuli
may induce phosphorylation of the investigated signaling mole-
cules. Nevertheless, the results suggest that IL-18 contributes
towards driving the detected NK cell response during acute
DENV infection.
NK cell homing to peripheral tissues plays a critical role in host
defense against many pathogens in murine models24–27,29,54,55.
This trafﬁcking is orchestrated by unique sets of chemokines
being produced by specialized cell types in different organs56. NK
cell homing patterns during acute infections in humans are not
well described. Nevertheless, in chronic inﬂammatory and auto-
immune conditions in humans it has been suggested that pri-
marily CD56bright NK cells use CXCR3, CCR5, and CCR8 to
localize inﬂamed skin and joints57–59. In light of this, we
undertook a comprehensive assessment of chemokine receptor
expression on NK cells during acute DENV infection with the
aim to identify chemokine receptor expression for tissues that are
affected during acute DENV infection. The results showed that
responding CD56bright NK cells transiently upregulated CLA,
CCR5, CXCR6, and CCR9. Intriguingly, this imprint was less
pronounced for CD56dim NK cells. The pattern of chemokine
receptor expression on CD56bright NK cells mirrored the pattern
displayed by responding T cells during acute DENV infection, as
previously reported45 and conﬁrmed in the present study. Since
priming of naive T cells occurs in lymph nodes during viral
infections, and since CD56bright NK cells are enriched at such
locations60, it is tempting to speculate that the priming of
CD56bright NK cells could take place there. If so, this would
provide a plausible explanation for the differences in chemokine
receptor proﬁles observed for CD56bright NK cells when com-
pared to CD56dim NK cells. Interestingly, we could also show that
primarily CD56bright NK cells were present in the skin during
acute infection. Furthermore, NK cells appeared to be rapidly
recruited to skin during acute infection since a negative correla-
tion was present between NK cell numbers per skin blister and
days after symptom debut. Finally, the NK cells present in skin
blister ﬂuid expressed high levels of CLA, CXCR3, and CCR5.
Previous studies of NK cells in acute DENV infection
demonstrated increased levels of CD69 expression on NK
cells61,62. Our results are in line with those earlier studies.
However, our data suggest expression of Ki67 to be a more robust
indicator of responding NK cells, since a larger fraction of both
CD56bright and CD56dim NK cells upregulated Ki67 early after
symptom debut. As previously shown after YFV vaccination,
Ki67 and CD69 were expressed in a largely mutually exclusive
pattern, suggesting these subsets of NK cells to represent different
phases of the response7. CD69 is an early activation marker for
cells in peripheral blood, whereas Ki67 is upregulated at later time
point when cells enter the cell cycle. During acute DENV infec-
tion, the detected Ki67 response was several orders of magnitude
stronger compared to the recently reported NK cell responses in
other ﬂavivirus infections, including YFV (attenuated YFV 17D)
and TBE infection7,8, and more in line with the potent responses
observed in, for example, acute hantavirus infection6. This might
be a reﬂection of how clinically severe the distinct acute phases of
these respective infection are.
Given the strong proliferative response observed during acute
DENV infection, it may be considered surprising that the fre-
quency of NK cells remains constant in peripheral blood. Fur-
thermore, NK cells retained expression of the anti-apoptotic
molecule Bcl-2 to a higher degree compared to responding T cells.
This may suggest active homing of responding cells to peripheral
tissues as an explanation for the constant levels of NK cells in
peripheral blood. Indeed, we could show that responding NK
cells, which share phenotypic features with their peripheral blood
counterparts, were present in the skin during acute DENV
infection. Notably, NK cells from skin blister ﬂuid expressed high
levels of CD69 during the acute phase of the infection, a marker
that has recently been associated with lymphocyte tissue
residency46,47. Interestingly, besides skin-resident cells such as
macrophages, Langerhans cells, and dendritic cells as potential
source of IL-18, keratinocytes can also produce IL-18. Further-
more, and in response to IFN-γ and TNF, keratinocytes can
produce ligands for CXCR3 (CXCL9, 10, and 11) and CCR5
(CCL3, 4, and 5)19,63,64. This may further augment the recruit-
ment of CXCR3- and CCR5-expressing cells, such as NK cells and
T cells. Previously cited literature in other conditions than acute
viral infections has indicated a role for CCR5 in skin homing. In
line with this, we detected increased expression of CCR5 on
responding CD56bright NK cells, suggesting that not only CLA but
perhaps also CXCR3 and CCR5 promote NK cell homing to skin
during acute DENV infection, receptors that have recently been
shown to be also expressed by DENV-speciﬁc T cells homing to
the skin45. A recent report also showed a role for CXCR6 on NK
cells in homing to skin after varicella zoster virus (VZV) skin
challenge65, whereas we could show that responding circulating
NK cells upregulated CXCR6. Unfortunately, we did not have the
possibility to investigate CXCR6 on NK cells in skin. However,
since CXCR6 has primarily been studied in relation to liver
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homing, it is plausible that CXCR6-expressing NK cells also
inﬁltrate the liver during DENV infection. Especially since many
patients display elevated levels of liver enzymes during acute
DENV infection. Previous literature has suggested a role for
CCR8 in NK cell homing to skin; however, because of technical
difﬁculties in performing ﬂow cytometry staining for this recep-
tor, we did not manage to assess a possible role for CCR8.
Intriguingly, an early report has associated lower levels of NK
cells in peripheral blood with dengue hemorrhagic fever62, a more
severe clinical presentation of acute infection than DF. Thus, it is
tempting to speculate that NK cells in the former patients have
entered peripheral tissues and contribute to clinical disease. In the
present study, patients with DF were included. Hence, no cor-
relations with disease activity (i.e., DF vs. dengue hemorrhagic
fever) could be performed. Nevertheless, our results provide as a
platform for future pathogenesis-oriented studies comparing
larger groups of patients, also with different disease presentations.
Such future studies should focus on determining if cytokine-
mediated or cytotoxic (such as rejection of infected cells) NK cell
responses are most important in disease pathogenesis. In this
regard, it is interesting to note that NK cells inﬁltrating skin after
VZV antigen challenge were CD107a+, suggestive of an ongoing
cytotoxic response65.
In summary, CD56bright and less mature CD56dim NK cells
were the main responding NK cells during acute DENV infection
in humans. The response correlated with increased levels of IL-18
in plasma and skin blister ﬂuid during acute DENV infection and
signaling downstream of IL-18Rα. A speciﬁc imprint of periph-
eral tissue homing was uniquely present within the CD56bright
NK cell compartment. Concomitantly, a corresponding NK cell
subset was identiﬁed in skin of patients during the acute phase of
infection. These results represent previously uncharacterized
features of NK cells during an acute viral infection in humans.
Methods
Study approval. Peripheral blood samples were longitudinally collected at Tan
Tock Seng Hospital from 32 patients with DENV infection (DF and one patient
with dengue hemorrhagic fever) throughout the acute, post-febrile, and con-
valescent phases of infection. Twenty-six community-matched healthy controls
were also sampled for peripheral blood and included in the study. Skin blister
samples were collected from eight DENV-infected patients during the acute phase
of infection as well as corresponding samples from ﬁve healthy controls. Ethical
regulations needed for working with human participants were obtained. All study
subjects gave written informed consent. The experiments were conducted
according to the Declaration of Helsinki and approved by the Singapore National
Healthcare Group ethical review board (DSRB 2013/00209 and DSRB 2008/00293).
Detailed clinical information of the DENV-infected patients is presented in Sup-
plementary Table 1.
Dengue diagnosis. The patients were diagnosed with acute DENV infection
through routine clinical diagnostics (detection of DENV RNA by reverse
transcription-polymerase chain reaction or NS1 antigen by enzyme-linked
immunosorbent assay (ELISA)). Patients that fulﬁlled the World Health Organi-
zation clinical criteria for acute DENV infection and were positive for immu-
noglobulin M (IgM) and IgG serology (Panbio Dengue Duo Casette) were also
included in the study. Secondary DENV infection was determined based on results
from the Panbio Dengue Duo IgM and IgG Rapid Strip Test or the SD Bioline NS1
antigen+ antibody combo (IgM and IgG antibody combination) test.
PBMC isolation. Blood was collected in EDTA-treated vacuum tubes at three
different time points (acute, post-febrile, and convalescent) after the onset of fever.
PBMCs were isolated using Ficoll-Hypaque gradient centrifugation and cryopre-
served in fetal calf serum (FCS) (Thermo Fisher Scientiﬁc) with 10% dimethyl
sulfoxide (Thermo Fisher Scientiﬁc) in liquid nitrogen for later analysis.
Skin blister induction and cell isolation. Suction skin blisters were induced on the
forearm of DENV-infected patients using skin suction chambers (Medical Engi-
neering, Royal Free Hospital) and a clinical suction pump66. Brieﬂy, a negative
pressure of 25–40 kPA was applied to the skin for 2 to 4 h until a unilocular blister
was formed. The blister was covered overnight with a rigid adhesive dressing. After
18 to 24 h, the accumulated ﬂuid inside the blister was aspirated and cells pelleted.
After removal of the supernatant, the pellet was resuspended in the AIM-V
medium (Thermo Fisher Scientiﬁc) supplemented with 2% AB human serum, and
the cells were analyzed by ﬂow cytometry as described below.
Measurement of plasma proteins during acute DENV infection. Plasma con-
centrations of IL-1β, IL-2, IL-6, IL-10, IL-12, IL-15, IL-18, TNF, IFNγ, granzyme A,
granzyme B, C5a/C5, vascular endothelial growth factor, and B cell-activating
factor were assessed using a custom-made magnetic luminex screening assay (R&D
Systems) according to the manufacturer’s instruction. IFNα was measured with a
multi-subtype type I interferon ELISA kit (PBL Assay Science) and IL-21 by using
an IL-21 ELISA kit (AH Diagnostics), both according to the protocols provided by
the manufacturers.
KIR and KIR ligand genotyping. Genomic DNA was isolated using a DNeasy
Blood & Tissue kit (Qiagen). KIR genotyping and KIR ligand determination were
performed using PCR-SSP (single-speciﬁc primer) technology with KIR and KIR
HLA ligand kits (Olerup) according to the manufacturer’s protocol. Alternatively,
KIR genotyping was performed using the PCR-SSO (sequence-speciﬁc oligonu-
cleotide) luminex-based method (OneLambda, Thermo Fisher). The KIR and HLA
genotypes of the patients are listed in Supplementary Table 2.
Flow cytometry. Ex vivo isolated PBMCs were thawed and stained with ﬂuores-
cently labeled antibodies. See Supplementary Table 3 for a complete list of anti-
bodies used. Biotinylated and puriﬁed antibodies were visualized using
streptavidin-coupled or anti-IgM secondary antibodies, respectively. Fixable LIVE/
DEAD Aqua or Blue dead cell stain kits (Life Technologies) were used to exclude
dead cells. For extracellular staining, samples were incubated for 20 min at room
temperature or for chemokine receptor staining for 30 min at 4 °C or 37 °C. After
ﬁxation/permeabilization using ﬁxation/permeabilization buffer (eBioscience),
PBMCs were stained intracellularly for 30 min in FACS Permwash buffer
(eBioscience) using the antibodies listed for intracellular staining in Supplementary
Table 3. The following reagent was obtained through the NIH AIDS Reagent
Program, Division of AIDS, NIAID, NIH: anti-human α4-β7 integrin monoclonal
(Act-1) (cat#11718) from Dr. A.A. Ansari67. Samples were acquired on BD LSR
Fortessa equipped with ﬁve lasers (BD Biosciences).
Functional analysis. Cryopreserved PBMCs were thawed in complete RPMI
medium, meaning RPMI-1640 medium (Thermo Fisher Scientiﬁc) supplemented
with 10% FCS (Thermo Fisher Scientiﬁc) and 1 mM L-glutamine (Invitrogen).
PBMCs were either rested or stimulated overnight with IL-12 (PeproTech) and IL-
18 (R&D Systems) at 37 °C and 5% CO2. For results from functional experiments
shown in Fig. 6, IL-12 was used at 10 ng/ml and IL-18 at 100 ng/ml. For results
from functional experiments shown in Supplementary Fig. 6, concentrations used
are indicated in the ﬁgure. After overnight incubation, 105 target cells, either K562
cells or 721.221 (.221) cells (both from ATCC), with or without Rituximab® (Rit, 1
μg/ml), were added to 106 rested or cytokine-stimulated PBMCs for additional 6 h.
Anti-CD107a FITC (BD Bioscience) was present throughout the assay. Monensin
and brefeldin A (BD Biosciences) were added during the ﬁnal 5 h. PBMCs were
subsequently stained with additional antibodies and analyzed by ﬂow cytometry as
described above.
Propagation of DENV stock. C6/36 mosquito cells were grown using supple-
mented Leibovitz’s L-15 medium (5% FCS, 1% PeSt, and 2% tryptose phosphate
(all from Thermo Fisher Scientiﬁc)) and infected with DENV type 2 (strain 4397-
11). Infected cells were incubated for 1 week. Supernatants were harvested from
infected and uninfected mosquito cells and stored at −80 °C.
Infection of PBMC with DENV. PBMCs from healthy donors were isolated by
density centrifugation (Ficoll-Hypaque from GE Healthcare). DENV stock was
exposed to ultraviolet (UV) light for 30 s in order to obtain an inactivated DENV
control. Supernatants from uninfected mosquito cells were used as mock infection
for uninfected controls (medium control). Viruses were diluted in RPMI medium
(RPMI-1640 medium (Thermo Fisher Scientiﬁc) supplemented with 10% FCS
(Thermo Fisher Scientiﬁc), 1% PeSt (Thermo Fisher Scientiﬁc) and 1 mM L-glu-
tamine (Invitrogen)) with or without the infection enhancing chimeric 4G2
monoclonal antibody (0.38 μg/ml) and incubated for 30 min at 4 °C. After the
incubation, PBMCs were pelleted and resuspended in the medium containing
DENV, UV-treated DENV, or mock, with or without the 4G2 monoclonal anti-
body. The cells were then incubated for 2 h at 37 °C and 5% CO2. Subsequently,
cells were centrifuged and washed once with complete RPMI medium. The PBMCs
were plated in duplicates as 106 cells per well and incubated overnight at 37 °C and
5% CO2 in complete RPMI medium. PBMCs were subsequently stained with
antibodies and analyzed by ﬂow cytometry as described above.
Detection of phospho-epitopes for cell signaling analysis. Ex vivo isolated
PBMCs from healthy donors were thawed and rested in complete RPMI medium
for 1 h at 37 °C and 5% CO2. Subsequently, PBMCs were stimulated with IL-18
(100 ng/ml; R&D Systems) or PBS (non-stimulated control) for 15 min at 37 °C
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and 5% CO2 in the presence of LIVE/DEAD Yellow (Life Technologies). For
in vitro experiments mimicking acute in vivo priming, NK cells were ﬁrst exposed
to IL-2 (Peprotech), IL-12 (Peprotech), IL-15 (Peprotech), and IFNα (PBL) at 2 ng/
ml or a pool of patient plasma diluted 1:2 in RPMI medium for 1 h. For ex vivo
analysis, PBMCs were thawed and directly ﬁxed without resting. IL-18 stimulation
was stopped with formaldehyde 2% (Polysciences) and cells were stained for
extracellular markers. After cell permeabilization with methanol, staining for
phospho-epitopes and perforin was performed. Fc receptor blocking (Miltenyi) was
included in all stains.
Flow cytometry data analysis. Flow cytometry data analysis was performed using
FlowJo version 9.9.4 (TreeStar). Post-processing was performed using SPICE ver-
sion 5.3 (provided by M. Roederer and J. Nozzi, NIAID, NIH) as well as R version
3.3.1 (The R Foundation of Statistical Computing). SNE analysis, a nonlinear
dimensionality reduction method making two-dimensional representations at the
single-cell level of highly complex data, was used to identify multivariate rela-
tionships as previously described32.
Statistics. Statistical analysis was performed using GraphPad Prism version 7
(GraphPad Software). Data were ﬁrst probed for normality using the
D’Agostino–Pearson omnibus test. For normally distributed data, paired or non-
paired, the Student’s t test or when comparing several groups one-way analysis of
variance followed by the Holm–Sidak’s multiple comparison test were used. For
non-normally distributed data, the Wilcoxon’s matched-pairs signed-rank test was
used for matched pairs of data and the Mann–Whitney test for unmatched pairs of
data. For multiple comparisons, Kruskal–Wallis test followed by Dunn’s multiple
comparisons test were used. Correlation analysis of non-normally distributed data
was performed with the Spearman’s correlation, and statistical signiﬁcance
exhibited *P < 0.05, **P < 0.01, and ***P < 0.001.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the ﬁndings of this study are available in the
article, the Supplementary information ﬁles, or upon request to the authors. The source
data underlying Figs. 1b–f, 2f, 3b, c, e–g, 4a, c–e, 5c–e, 6b, d, 7b, 8b, c, f, g and
Supplementary Figs. 1b–e, 2b, c, e, 3a, b, 4a, 5c, 6a–c, 7a, 8b are provided as a Source
Data ﬁle.
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